• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Growing Understanding of the Clinical and Serologic Effects of COVID-19 Vaccines in Patients Undergoing Long-Term Dialysis.对长期透析患者接种新冠疫苗的临床和血清学影响的认识不断加深。
Clin J Am Soc Nephrol. 2022 Mar;17(3):335-337. doi: 10.2215/CJN.00320122. Epub 2022 Feb 10.
2
Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients.维持性透析患者对SARS-CoV-2疫苗的血清反应。
Am J Kidney Dis. 2022 Feb;79(2):307-310. doi: 10.1053/j.ajkd.2021.10.002. Epub 2021 Nov 7.
3
Antibody levels following booster SARS-CoV-2 vaccination among dialysis patients initially vaccinated with adenovirus vector-based vaccine.最初接种基于腺病毒载体疫苗的透析患者接种SARS-CoV-2加强疫苗后的抗体水平。
J Nephrol. 2023 Apr;36(3):609-611. doi: 10.1007/s40620-022-01559-8. Epub 2023 Jan 23.
4
SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?透析患者中的新型冠状病毒2型疫苗：是时候加强接种了吗？
Am J Kidney Dis. 2022 Feb;79(2):162-163. doi: 10.1053/j.ajkd.2021.10.003. Epub 2021 Dec 23.
5
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
6
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
7
Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.腹膜透析和血液透析患者对 SARS-CoV-2 mRNA 疫苗的长期抗体反应比较。
Nephrol Dial Transplant. 2022 Feb 25;37(3):602-604. doi: 10.1093/ndt/gfab321.
8
Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients.透析患者接种新型冠状病毒2型BNT162b2 mRNA疫苗的经验
Kidney Int. 2021 Jun;99(6):1496-1498. doi: 10.1016/j.kint.2021.04.006. Epub 2021 Apr 20.
9
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.慢性透析患者 COVID-19 疫苗接种的免疫原性。
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
10
Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders.接受维持性血液透析的患者接种新型冠状病毒2疫苗后的体液免疫反应：免疫丧失、第三剂疫苗和无反应者
Nephrol Dial Transplant. 2022 Jan 25;37(2):390-392. doi: 10.1093/ndt/gfab299.

引用本文的文献

1
Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis.血液透析患者对第三剂BNT162b2的良好体液反应。
J Clin Med. 2022 Apr 8;11(8):2090. doi: 10.3390/jcm11082090.

本文引用的文献

1
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
2
Vaccination and COVID-19 Dynamics in Dialysis Patients.接种疫苗与透析患者的 COVID-19 动力学
Clin J Am Soc Nephrol. 2022 Mar;17(3):395-402. doi: 10.2215/CJN.10300721. Epub 2022 Feb 10.
3
SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis.接受透析患者的新冠病毒疫苗抗体反应及突破性感染
Ann Intern Med. 2022 Mar;175(3):371-378. doi: 10.7326/M21-4176. Epub 2021 Dec 14.
4
Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.血液透析患者对 SARS-CoV-2 mRNA 疫苗的体液和细胞免疫应答的预测因素和动力学：一项多中心观察性研究。
J Am Soc Nephrol. 2021 Dec 1;32(12):3208-3220. doi: 10.1681/ASN.2021070908.
5
Immunogenicity of SARS-CoV-2 Vaccine in Dialysis.血液透析患者的 SARS-CoV-2 疫苗免疫原性。
J Am Soc Nephrol. 2021 Nov;32(11):2735-2742. doi: 10.1681/ASN.2021040432. Epub 2021 Aug 4.
6
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
7
COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective.维持性透析患者的 COVID-19 疫苗接种必要性：国际视角
Clin J Am Soc Nephrol. 2021 Nov;16(11):1746-1748. doi: 10.2215/CJN.07260521. Epub 2021 Jul 19.
8
COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.美国透析患者中的 COVID-19：来自全国透析服务提供商的数据显示的风险因素和结果。
Am J Kidney Dis. 2021 May;77(5):748-756.e1. doi: 10.1053/j.ajkd.2021.01.003. Epub 2021 Jan 17.
9
Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study.成人肾脏替代治疗患者 COVID-19 的发病情况、特征和结局：一项区域登记研究。
J Am Soc Nephrol. 2021 Feb;32(2):385-396. doi: 10.1681/ASN.2020060875. Epub 2020 Nov 5.
10
Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic.保障维护性血液透析患者在 2019 冠状病毒病大流行期间的安全。
Blood Purif. 2020;49(3):259-264. doi: 10.1159/000507537. Epub 2020 Apr 1.

Growing Understanding of the Clinical and Serologic Effects of COVID-19 Vaccines in Patients Undergoing Long-Term Dialysis.

作者信息

Hundemer Gregory L, Sood Manish M

机构信息

Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

出版信息

Clin J Am Soc Nephrol. 2022 Mar;17(3):335-337. doi: 10.2215/CJN.00320122. Epub 2022 Feb 10.

DOI:10.2215/CJN.00320122
PMID:35144971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8975028/
Abstract
摘要